According to Research by SNS Insider, U.S. Capnography Devices Market Hits USD 195.26 Million in 2023, Projected to Reach USD 461.29 Million by 2032 with 9.37% CAGR, Driven by Expanding Critical Care ...

A total of 103 children, between the ages of 0 -18, in Eastern Highlands Province have undergone a free Paediatric Cardiac ...

A large study led by Australian researchers has found a significant increase in obstructive sleep apnoea on weekends. But ...

The diagnosis of chronic obstructive pulmonary disease, or COPD, is improved by incorporating CT lung imaging and respiratory ...

Brensocatib (Brinsupri; Insmed) gains FDA approval as the first treatment for bronchiectasis, offering hope to patients with ...

Brinsupri is the first approved therapy to address the underlying inflammatory process of non-cystic fibrosis bronchiectasis ...

The Guam Department of Public Health and Social Services has confirmed an uptick in respiratory viral activity on the island, ...

The FDA granted approval to brensocatib for treating adults and children aged at least 12 years with non-cystic fibrosis ...

The GMCH-32, which serves not only the tricity but also patients from Punjab, Haryana and Himachal Pradesh, received 95 ventilators during the COVID-19 pandemic at an estimated cost of ₹4 lakh each ...

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 Productive initial meeting ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Researchers have developed a new engineered protein-based therapy, which acts like a sponge to soak up carbon monoxide from ...